Health Trials

Registry of Subjects at Risk of Pancreatic Cancer

ConditionsFamilial Pancreatic CancerBRCA1 MutationBRCA2 MutationLynch SyndromeFAMMM - Familial Atypical Mole Malignant Melanoma SyndromeHereditary PancreatitisPeutz-Jeghers Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorAssociazione Italiana per lo Studio del Pancreas

About this trial

IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.

Eligibility criteria

Qualifiers

individuals with at least two relatives suffering from pancreatic cancer, with at least 1 first-degree and until the third-degree

subjects with known genetic mutation of BRCA2, BRCA1, p16, PALB2 with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer

subjects suffering from FAMMM Syndrome

subjects suffering from Peutz-Jeghers Syndrome

Disqualifiers

None

Trial design

Treatments tested in this trial

  • MRCP
  • Endoultrasonography

Treatment groups

1,000 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators

Associazione Italiana per lo Studio del Pancreas

Lead sponsor

Source ClinicalTrials.gov